Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Lymphoid infiltration as a prognostic variable for early-onset breast carcinomasS Ménard, G Tomasic, P Casalini, et al.
Breast Cancer Research and Treatment|September 11, 1999
Pathobiologic identification of two distinct breast carcinoma subsets with diverging clinical behaviorsS Ménard, P Casalini, G Tomasic, et al.
International Journal of Cancer|April 1, 1991
Selection of monoclonal antibodies which induce internalization and phosphorylation of p185HER2 and growth inhibition of cells with HER2/NEU gene amplificationE Tagliabue, F Centis, M Campiglio, et al.
British Journal of Haematology|July 1, 1995
Differential sensitivity of CD30+ neoplastic cells to gelonin delivered by anti-CD30/anti-gelonin bispecific antibodiesS Sforzini, A Bolognesi, R Meazza, et al.
Annals of Surgery|June 22, 2000
Breast cancer patients treated without axillary surgery: clinical implications and biologic analysisM Greco, R Agresti, N Cascinelli, et al.
International Journal of Cardiac Imaging|January 1, 1985
Non-selective intra-arterial digital subtraction angiography for the assessment of coronary artery bypass graftsG Steffenino, B Meier, P Bopp, et al.
The American Journal of Pathology|November 7, 1999
Fluctuation of HER2 expression in breast carcinomas during the menstrual cycleA Balsari, P Casalini, E Tagliabue, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variablesS Ménard, P Valagussa, S Pilotti, et al.
British Journal of Cancer|July 31, 1998
Biochemical modifications of avidin improve pharmacokinetics and biodistribution, and reduce immunogenicityM Chinol, P Casalini, M Maggiolo, et al.
Oncogene|September 20, 2016
Pathobiological implications of the d16HER2 splice variant for stemness and aggressiveness of HER2-positive breast cancerL Castagnoli, G C Ghedini, A Koschorke, et al.
Pageof 4